Mis-trafficking of endosomal urokinase proteins triggers drug-induced glioma nonapoptotic cell death

Molecular Pharmacology

Volumn 87, Issue 4, 2015, Pages 683-696

  Pasupuleti, Nagarekha ^a,b   Grodzki, Ana Cristina ^a,b   Gorin, Fredric ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; PLASMINOGEN ACTIVATOR INHIBITOR 1; UCD 38B; UNCLASSIFIED DRUG; UROKINASE; UROKINASE RECEPTOR; 5-BENZYLGLYCINYL AMILORIDE; AMILORIDE; APOPTOSIS INDUCING FACTOR; GLYCINE; LOW DENSITY LIPOPROTEIN RECEPTOR RELATED PROTEIN; LRP1 PROTEIN, HUMAN; SERPINE1 PROTEIN, HUMAN;

ARTICLE; CELL DEATH; CELL MEMBRANE; CONTROLLED STUDY; DEPOLARIZATION; ENDOCYTOSIS; ENDOSOME; GENE TRANSLOCATION; GLIOMA; GLIOMA CELL LINE; HUMAN; HUMAN CELL; PRIORITY JOURNAL; ANALOGS AND DERIVATIVES; BRAIN TUMOR; DRUG EFFECTS; ENZYMOLOGY; METABOLISM; MITOCHONDRION; NECROSIS; PATHOLOGY; PROTEIN TRANSPORT; TUMOR CELL LINE;

AMILORIDE; ANTINEOPLASTIC AGENTS; APOPTOSIS INDUCING FACTOR; BRAIN NEOPLASMS; CELL LINE, TUMOR; ENDOCYTOSIS; ENDOSOMES; GLIOMA; GLYCINE; HUMANS; LOW DENSITY LIPOPROTEIN RECEPTOR-RELATED PROTEIN-1; MITOCHONDRIA; NECROSIS; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROTEIN TRANSPORT; RECEPTORS, UROKINASE PLASMINOGEN ACTIVATOR; UROKINASE-TYPE PLASMINOGEN ACTIVATOR;

EID: 84982121558     PISSN: 0026895X     EISSN: 15210111     Source Type: Journal    
DOI: 10.1124/mol.114.096602     Document Type: Article

References (36)

1. Andreasen PA (2007) PAI-1-a potential therapeutic target in cancer. Curr Drug Targets 8:1030-1041.
2. Andreasen PA, Kjoller L, Christensen L, and Duffy MJ (1997) The urokinase-type plasminogen activator system in cancer metastasis: a review. Int J Cancer 72:1-22.
3. Bajou K, Maillard C, Jost M, Lijnen RH, Gils A, Declerck P, Carmeliet P, Foidart JM, and Noel A (2004) Host-derived plasminogen activator inhibitor-1 (PAI-1) concentration is critical for in vivo tumoral angiogenesis and growth. Oncogene 23:6986-6990.
4. Blasi F, Vassalli JD, and Danø K (1987) Urokinase-type plasminogen activator: proenzyme, receptor, and inhibitors. J Cell Biol 104:801-804.
5. Buckner JC, Brown PD, O'Neill BP, Meyer FB, Wetmore CJ, and Uhm JH (2007) Central nervous system tumors. Mayo Clin Proc 82:1271-1286.
6. Calore F, Genisset C, Casellato A, Rossato M, Codolo G, Esposti MD, Scorrano L, and de Bernard M (2010) Endosome-mitochondria juxtaposition during apoptosis induced by H. pylori VacA. Cell Death Differ 17:1707-1716.
7. Conese M, Nykjaer A, Petersen CM, Cremona O, Pardi R, Andreasen PA, Gliemann J, Christensen EI, and Blasi F (1995) alpha-2 Macroglobulin receptor/Ldl receptorrelated protein(Lrp)-dependent internalization of the urokinase receptor. J Cell Biol 131:1609-1622.
8. Cortese K, Sahores M, Madsen CD, Tacchetti C, and Blasi F (2008) Clathrin and LRP-1-independent constitutive endocytosis and recycling of uPAR. PLoS ONE 3:e3730.
9. Crompton M (1999) The mitochondrial permeability transition pore and its role in cell death. Biochem J 341:233-249.
10. Czekay RP, Aertgeerts K, Curriden SA, and Loskutoff DJ (2003) Plasminogen activator inhibitor-1 detaches cells from extracellular matrices by inactivating integrins. J Cell Biol 160:781-791.
11. Dunn IF and Black PM (2003) The neurosurgeon as local oncologist: cellular and molecular neurosurgery in malignant glioma therapy. Neurosurgery 52:1411-1422.
12. Ellis V, Scully MF, and Kakkar VV (1989) Plasminogen activation initiated by singlechain urokinase-type plasminogen activator. Potentiation by U937 monocytes. J Biol Chem 264:2185-2188.
13. Feoktistova M, Geserick P, Panayotova-Dimitrova D, and Leverkus M (2012) Pick your poison: the Ripoptosome, a cell death platform regulating apoptosis and necroptosis. Cell Cycle 11:460-467.
14. Fulda S (2013) The mechanism of necroptosis in normal and cancer cells. Cancer Biol Ther 14:999-1004.
15. García-Ruiz C, Colell A, Morales A, Calvo M, Enrich C, and Fernández-Checa JC (2002) Trafficking of ganglioside GD3 to mitochondria by tumor necrosis factoralpha. J Biol Chem 277:36443-36448.
16. Grant BD and Donaldson JG (2009) Pathways and mechanisms of endocytic recycling. Nat Rev Mol Cell Biol 10:597-608.
17. Harbeck N, Schmitt M, Meisner C, Friedel C, Untch M, Schmidt M, Sweep CG, Lisboa BW, Lux MP, and Beck T et al.; Chemo-N 0 Study Group (2013) Ten-year analysis of the prospective multicentre Chemo-N0 trial validates American Society of Clinical Oncology (ASCO)-recommended biomarkers uPA and PAI-1 for therapy decision making in node-negative breast cancer patients. Eur J Cancer 49:1825-1835.
18. Harley W, Floyd C, Dunn T, Zhang XD, Chen TY, Hegde M, Palandoken H, Nantz MH, Leon L, and Carraway KL, 3rd et al. (2010) Dual inhibition of sodiummediated proton and calcium efflux triggers non-apoptotic cell death in malignant gliomas. Brain Res 1363:159-169.
19. Herz J, Clouthier DE, and Hammer RE (1992) LDL receptor-related protein internalizes and degrades uPA-PAI-1 complexes and is essential for embryo implantation. Cell 71:411-421.
20. Herz J, Hamann U, Rogne S, Myklebost O, Gausepohl H, and Stanley KK (1988) Surface location and high affinity for calcium of a 500-kd liver membrane protein closely related to the LDL-receptor suggest a physiological role as lipoprotein receptor. EMBO J 7:4119-4127.
21. Leon LJ, Pasupuleti N, Gorin F, and Carraway KL, 3rd (2013) A cell-permeant amiloride derivative induces caspase-independent, AIF-mediated programmed necrotic death of breast cancer cells. PLoS ONE 8:e63038.
22. Marshall KD and Baines CP (2014) Necroptosis: is there a role for mitochondria? Front Physiol 5:323.
23. Marzo I, Brenner C, Zamzami N, Jürgensmeier JM, Susin SA, Vieira HL, Prévost MC, Xie Z, Matsuyama S, and Reed JC et al. (1998) Bax and adenine nucleotide translocator cooperate in the mitochondrial control of apoptosis. Science 281: 2027-2031.
24. Massey AP, Harley WR, Pasupuleti N, Gorin FA, and Nantz MH (2012) 2-Amidino analogs of glycine-amiloride conjugates: inhibitors of urokinase-type plasminogen activator. Bioorg Med Chem Lett 22:2635-2639.
25. Mattson MP, LaFerla FM, Chan SL, Leissring MA, Shepel PN, and Geiger JD (2000) Calcium signaling in the ER: its role in neuronal plasticity and neurodegenerative disorders. Trends Neurosci 23:222-229.
26. Maxfield FR and McGraw TE (2004) Endocytic recycling. Nat Rev Mol Cell Biol 5: 121-132.
27. Meley D, Bauvy C, Houben-Weerts JH, Dubbelhuis PF, Helmond MT, Codogno P, and Meijer AJ (2006) AMP-activated protein kinase and the regulation of autophagic proteolysis. J Biol Chem 281:34870-34879.
28. Olson D, Pöllänen J, Høyer-Hansen G, Rønne E, Sakaguchi K, Wun TC, Appella E, Danø K, and Blasi F (1992) Internalization of the urokinase-plasminogen activator inhibitor type-1 complex is mediated by the urokinase receptor. J Biol Chem 267: 9129-9133.
29. Ouasti S, Matarrese P, Paddon R, Khosravi-Far R, Sorice M, Tinari A, Malorni W, and Degli Esposti M (2007) Death receptor ligation triggers membrane scrambling between Golgi and mitochondria. Cell Death Differ 14:453-461.
30. Palandoken H, By K, Hegde M, Harley WR, Gorin FA, and Nantz MH (2005) Amiloride peptide conjugates: prodrugs for sodium-proton exchange inhibition.J Pharmacol Exp Ther 312:961-967.
31. Pasupuleti N, Leon L, Carraway KL, 3rd, and Gorin F (2013) 5-Benzylglycinylamiloride kills proliferating and nonproliferating malignant glioma cells through caspase-independent necroptosis mediated by apoptosis-inducing factor. J Pharmacol Exp Ther 344:600-615.
32. Schmitt M, Harbeck N, Thomssen C, Wilhelm O, Magdolen V, Reuning U, Ulm K, Höfler H, Jänicke F, and Graeff H (1997) Clinical impact of the plasminogen activation system in tumor invasion and metastasis: prognostic relevance and target for therapy. Thromb Haemost 78:285-296.
33. Setyono-Han B, Stürzebecher J, Schmalix WA, Muehlenweg B, Sieuwerts AM, Timmermans M, Magdolen V, Schmitt M, Klijn JG, and Foekens JA (2005) Suppression of rat breast cancer metastasis and reduction of primary tumour growth by the small synthetic urokinase inhibitor WX-UK1. Thromb Haemost 93:779-786.
34. Shintani T and Klionsky DJ (2004) Autophagy in health and disease: a double-edged sword. Science 306:990-995.
35. Taylor DR and Hooper NM (2007) The low-density lipoprotein receptor-related protein 1 (LRP1) mediates the endocytosis of the cellular prion protein. Biochem J 402:17-23.
36. Ulisse S, Baldini E, Sorrenti S, and D'Armiento M (2009) The urokinase plasminogen activator system: a target for anti-cancer therapy. Curr Cancer Drug Targets 9:32-71.